Pound Capital logo

Pound Capital

North America, Connecticut, United States, Stamford

Description

Pound Capital is a venture capital firm investing in early and growth-stage companies.

Investor Profile

Pound Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Hospital.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Hospital
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pound Capital frequently co-invest with?

Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 1
TC
Europe, Nordrhein-Westfalen, Germany, Düsseldorf
Co-Investments: 1
Nexus Medical Partners
North America, Massachusetts, United States, Quincy
Co-Investments: 1
Excalibur Fund Managers
Europe, England, United Kingdom, London
Co-Investments: 1
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Alpha Associates
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Apax Partners
Europe, England, United Kingdom, London
Co-Investments: 1
Burrill & Company
North America, California, United States, San Francisco
Co-Investments: 1
M
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by Pound Capital?

Neurotech

Lincoln, Rhode Island, United States

Neurotech is a biotechnology company developing sight-saving therapeutics for chronic retinal diseases.

BiotechnologyHealth CareHospitalMedicalPharmaceuticalTherapeuticsWellness
Series BNov 16, 2006
Amount Raised: $35,000,000